Peptides for Thyroid Health: Thyrotropin-Releasing Hormone and Thyroid Optimization

Written by Adam Maggio | Medically reviewed by Dr. Sarah Chen, PharmD, BCPS

TRH (Thyrotropin-Releasing Hormone) is a tripeptide that stimulates TSH and thyroid hormone production. It has been studied for hypothyroidism, depression, and cognitive enhancement. Thyroid optimization is often a prerequisite for optimal response to other hormone therapies including TRT.

The Thyroid-Hormone Connection

The thyroid gland produces hormones (T4 and T3) that regulate metabolism, energy production, body temperature, heart rate, and virtually every other physiological process. Thyroid dysfunction — particularly hypothyroidism — is one of the most common endocrine disorders, affecting an estimated 20 million Americans. Importantly, thyroid function is intimately connected to the effectiveness of other hormone therapies: suboptimal thyroid function can blunt the response to TRT, growth hormone therapy, and other interventions.

TRH: The Thyroid Peptide

Thyrotropin-Releasing Hormone (TRH) is a tripeptide (Glu-His-Pro) produced by the hypothalamus that stimulates the pituitary to release TSH (thyroid-stimulating hormone), which in turn stimulates the thyroid to produce T4 and T3. As a research peptide, TRH has been studied for its effects on thyroid function, depression, cognitive enhancement, and neuroprotection. TRH has direct effects on the brain independent of its thyroid-stimulating effects, including antidepressant and cognitive-enhancing properties.

Subclinical Hypothyroidism

Subclinical hypothyroidism — defined as elevated TSH with normal T4 — is common and often undertreated. Symptoms include fatigue, weight gain, cold intolerance, constipation, brain fog, and depression — symptoms that overlap significantly with low testosterone and other hormone deficiencies. Treating subclinical hypothyroidism can significantly improve the response to TRT and other hormone therapies.

Thyroid Optimization Protocol

A comprehensive thyroid evaluation should include: TSH, free T4, free T3, reverse T3, and thyroid antibodies (TPO and TG antibodies). Optimal ranges differ from laboratory reference ranges: TSH 1–2 mIU/L, free T4 in the upper half of the reference range, free T3 in the upper third of the reference range, and reverse T3 below 15 ng/dL. Treatment options range from lifestyle interventions (selenium, iodine, zinc supplementation) to thyroid hormone replacement (T4 alone or T4+T3 combination).